from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3351c/-

LFCtreatmentdescriptionclass of inhibitor

0.680

Amikacinug/mL Amikacintranslation

0.564

Cap5-10ug/mL Capreomycintranslation

0.292

Rox10-50 ug/mL Roxithromycintranslation

0.000

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

-0.135

Rif0.2-5ug/mL Rifampicintranscription

0.187

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.791

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.524

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.304

CPZ10-50 ug/mL Chlorpromazinerespiration

0.164

Clofazimine10-13 ug/mL Clofaziminerespiration

0.044

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.168

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.314

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.645

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.821

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.000

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.211

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.117

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.049

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.060

KCN5-20 ug/mL Potassium cyaniderespiration

0.000

NaN30.2-2 mM Sodium aziderespiration

-0.931

Nigericin50 uM Nigericinrespiration

0.027

TRC10-150 ug/mL Triclosanrespiration

0.321

TRZ10-25 ug/mL Thioridazinerespiration

-0.417

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-0.479

menadione6-10 ug/mL Menadionerespiration

-0.042

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.328

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.692

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.068

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.438

NRP_1Non-replicating persistence stage 1dosRassociated

-0.902

Amp0.2mg/mL AmpicillincellWall

-0.304

Cephalexin20-100 ug/mL CephalexincellWall

0.444

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.015

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.892

EMB10-20 ug/mL EthambutolcellWall

0.000

Eta12-40 ug/mL EthionamidecellWall

0.000

INH0.2-0.4 ug/mL IsoniazidcellWall

0.000

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.162

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.094

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.048

BZA0.12 mg/mL BenzamidearomaticAmides

-0.101

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.081

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.332

H2O24 mM hydrogen peroxideDNAdamaging

-0.183

Levo10 ug/mL LevofloxacinDNAdamaging

0.265

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.117

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.241

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.114

UVUV-irradiationDNAdamaging

-0.916

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.732

Antimycin12.5-50 ug/mL Antimycin A?

-0.812

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.451

PA_110-50 ug/mL Antitubercular compound PA-1?

0.222

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.263

PA8240.2-2 ug/mL PA-824?

-1.304

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.816

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.919

Verapamil50 uM Verapamil?

-1.661

mercaptoethanol2 mM 2-Mercaptoethanol?

0.085

methoxatin10-20 ug/mL Methoxatin?